Literature DB >> 7315856

Reduction in antibiotic costs by restricting use of an oral cephalosporin.

S J Seligman.   

Abstract

Antibiotic cost control programs are important; however, they may be difficult to implement if they include intensive involvement of infectious diseases specialists. In a large municipal hospital, review of antibiotic cost data indicated that 31 percent of the total antibiotic expenditure was for an oral cephalosporin, cephalexin. The requirement that an antibiotic justification form be completed did not decrease use of the drug. However, the requirement that the prescribing physician telephone an infectious diseases specialist resulted in marked restriction of the oral cephalosporin and was accompanied by a 29 percent reduction (adjusted for inflation) in total antibiotic costs. Since comparatively few telephone requests were made and since the decision process to use an oral cephalosporin is comparatively simple, marked reduction in antibiotic costs was achieved with relatively little effort by the infectious disease expert.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7315856     DOI: 10.1016/0002-9343(81)90304-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  Antimicrobial stewardship.

Authors:  Shira Doron; Lisa E Davidson
Journal:  Mayo Clin Proc       Date:  2011-11       Impact factor: 7.616

2.  Effect of reactive pharmacy intervention on quality of hospital prescribing.

Authors:  C J Hawkey; S Hodgson; A Norman; T K Daneshmend; S T Garner
Journal:  BMJ       Date:  1990-04-14

Review 3.  Antimicrobial therapy. Cost-benefit considerations.

Authors:  B J Guglielmo; G F Brooks
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

Review 4.  The role of the infectious diseases physician in monitoring antimicrobial use: a pharmacy perspective.

Authors:  R E Polk
Journal:  Bull N Y Acad Med       Date:  1987 Jul-Aug

5.  Antimicrobial stewardship: attempting to preserve a strategic resource.

Authors:  Trevor Van Schooneveld
Journal:  J Community Hosp Intern Med Perspect       Date:  2011-07-18

6.  Generic antibiotic industries: Challenges and implied strategies with regulatory perspectives.

Authors:  M Venkatesh; V G Bairavi; K C Sasikumar
Journal:  J Pharm Bioallied Sci       Date:  2011-01

Review 7.  Impact of formulary restriction with prior authorization by an antimicrobial stewardship program.

Authors:  Erica E Reed; Kurt B Stevenson; Jessica E West; Karri A Bauer; Debra A Goff
Journal:  Virulence       Date:  2012-11-15       Impact factor: 5.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.